Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
9.33
+0.11 (1.19%)
Mar 14, 2025, 11:31 AM EDT - Market open

Intellia Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
9661,1882,7312,9748,7993,514
Upgrade
Market Cap Growth
-56.51%-56.51%-8.18%-66.20%150.41%390.02%
Upgrade
Enterprise Value
3243441,8562,2237,7273,128
Upgrade
Last Close Price
9.2211.6630.4934.89118.2454.40
Upgrade
PS Ratio
15.7520.5275.2757.06266.2260.59
Upgrade
PB Ratio
1.081.362.602.418.466.67
Upgrade
P/TBV Ratio
1.361.362.602.418.466.67
Upgrade
EV/Sales Ratio
5.605.9551.1742.65233.7653.94
Upgrade
Debt / Equity Ratio
0.240.240.110.110.070.07
Upgrade
Asset Turnover
0.050.050.030.040.030.11
Upgrade
Quick Ratio
5.505.508.239.455.979.33
Upgrade
Current Ratio
5.775.778.679.616.119.59
Upgrade
Return on Equity (ROE)
-54.00%-54.00%-42.10%-41.67%-34.18%-33.69%
Upgrade
Return on Assets (ROA)
-26.80%-26.80%-22.83%-20.35%-16.99%-16.89%
Upgrade
Return on Capital (ROIC)
-29.71%-29.71%-25.44%-23.09%-19.92%-19.98%
Upgrade
Earnings Yield
-53.20%-43.71%-17.62%-15.95%-3.04%-3.82%
Upgrade
FCF Yield
-36.35%-29.86%-14.94%-11.66%-2.70%-1.52%
Upgrade
Buyback Yield / Dilution
-11.35%-11.35%-15.33%-8.57%-26.63%-18.50%
Upgrade
Total Shareholder Return
-11.35%-11.35%-15.33%-8.57%-26.63%-18.50%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.